Audit 1 claim. Output YAML only.

CLAIM (POLARIS Q5 Pharmacare Long-term Outcomes):
"In terms of expenditure control, Quebec's regime did not reduce taxpayer-financed drug expenditures and substantially increased employer- and household-financed expenditures."

CITED [4]: Morgan et al. CMAJ 2017 + similar pharmacare comparative literature.

PRIMARY-SOURCE CONTEXT:
- Morgan et al. CMAJ 2017 analysis of Quebec's hybrid public-private system documented:
  - Taxpayer-financed (public RAMQ) drug expenditure: NOT reduced relative to comparators
  - Employer- and household-financed (private + out-of-pocket) drug expenditure: SUBSTANTIALLY INCREASED relative to ROC growth rates
- This is a qualitative directional finding well-documented in Morgan 2017
- The "$1.7 billion less per year" counterfactual (verified earlier as Q5-C8) is the quantitative complement to this qualitative claim

AUDIT: Is the qualitative claim (Quebec public expenditure not reduced, private/employer expenditure increased) consistent with Morgan et al. CMAJ 2017 documented findings?

Output YAML:
```yaml
claim_id: POLARIS-Q5-C9
cited_source_tier: T2_T3
primary_source_verified: yes
verdict: VERIFIED | PARTIAL | UNSUPPORTED | FABRICATED | UNREACHABLE
reason: "one sentence"
```
